Michael E. Phillips
Keine laufenden Positionen mehr
Profil
Michael E.
Phillips has been Chairman of Xillix Technologies Corp.
since 2002.
He joined Xillix in 1994.
He was Senior Vice President of Investment for GrowthWorks Capital.
He has over 20 years of direct venture capital experience.
He was Investment Manager for Vencap Equities Albert Ltd.
He received a Bachelor of Commerce degree from Simon Fraser University.
Ehemalige bekannte Positionen von Michael E. Phillips
| Unternehmen | Position | Ende |
|---|---|---|
Biomerge Industries Ltd.
 Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Vorsitzender | 28.05.2009 |
Ausbildung von Michael E. Phillips
| Simon Fraser University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Biomerge Industries Ltd.
Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Health Technology |
